Aldeyra Therapeutics, Inc. Cash Flow Statement

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -3.84M-7.51M-12.09M-18.70M-22.34M-38.89M-60.83M-37.55M-57.78M-62.02M-37.54M-55.85M
Depreciation and Depletion 0.00M0.02M0.04M0.04M0.07M0.10M0.06M0.26M0.26M0.26M0.25M
Share-based Compensation 1.70M2.04M2.19M2.76M2.71M4.14M8.08M7.08M7.11M8.29M5.75M7.97M
Deferred Taxes -1.31M-0.48M
Gains from Investment Securities -2.33M2.45M0.53M0.13M
Cash from Operations -1.71M-4.78M-9.31M-15.15M-19.22M-29.86M-44.98M-37.49M-42.56M-56.64M-30.33M-43.21M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.12M0.15M0.04M-0.27M-0.13M0.24M0.58M0.57M0.41M0.33M0.35M1.67M
Depreciation & Amortization (CF) 0.00M0.02M0.04M0.04M0.07M0.10M0.06M0.26M0.26M0.26M0.25M
Change in Working Capital
Change in Account Payables 0.27M-0.00M0.51M-0.58M0.73M2.05M-2.85M-0.43M0.64M-0.89M1.20M-1.16M
Change in Accured Expenses -0.01M0.78M0.29M0.76M0.29M3.10M6.04M-5.01M4.56M1.20M-8.08M5.00M
Other Working Capital Changes 0.01M0.22M0.26M-0.28M0.80M0.15M0.45M3.40M-2.24M3.76M-1.73M-2.07M
Investing Activities
Capital Expenditures 0.01M0.09M0.01M0.02M0.26M0.01M0.01M0.02M
Acquisitions 0.61M
Change in Acquisitions & Divestments 15.84M24.92M36.66M75.64M34.80M63.00M30.00M52.00M
Cash from Investing Activities -0.01M-13.04M-0.23M-10.20M-23.34M18.48M29.02M-0.01M-29.95M30.00M-44.92M
Financing Activities
Other financing activities 0.12M1.04M0.29M
Cash from Financing Activities 3.75M10.06M28.47M12.74M37.43M80.53M23.58M41.90M194.50M1.22M-1.27M-0.17M
Additional items
Change in Cash 2.04M5.26M6.12M-2.63M8.01M27.33M-2.93M33.43M151.93M-85.37M-1.60M-88.30M
Free Cash Flow -1.71M-4.79M-9.40M-15.16M-19.25M-30.12M-44.99M-37.49M-42.56M-56.65M-30.33M-43.21M
Net Cash Flow 2.04M5.26M6.12M-2.63M8.01M27.33M-2.93M33.43M151.93M-85.37M-1.60M-88.30M